File of the category ‘Factors of Transference’
On January 5, 2011 |
Salt Lake City, Utah (January 3, 2011)
4Life Research ™ announced today that the Office of patents and registered marks of the United States (USPTO) has granted to the company a patent of composition, which protects the formula 4Life Transfer Factor ® until the year 2025. This is the sixth patent of the company on a global scale. 4Life it has numerous international patents and dozens of requests of hanging patents. 4Life tiene numerosas patentes internacionales y docenas de solicitudes de patentes pendientes.
The progressive science and the search of the protection of patents strengthens the business opportunity for the distributors with the exclusive right to commercialize the products of 4Life Transfer Factor ®. The President of 4Life Steve Tew commented: "We invest big resources in the protection of our patents on behalf of our distributors because we know that the opportunity that they share will have to be accompanied by the class of exclusivity, credibility and longevity that the patents provide”.
The commitment that 4Life it has with the patents includes an emphasis on the research and development to generate formulae, compositions and processes that are subject to be patent. As the legal team of 4Life concentrates on the patents acquisition, the department of international record of products focuses in registering the products about the world to endorse the growth of the distributors so much now as in the future. During 2010, 4Life it completed the record of 101 products in 30 countries. Durante el 2010, 4Life completó el registro de 101 productos en 30 países.
The Founder and Director-general Ejecutivo of 4Life David Lisonbee said: "The patents protection is an only one way at which we are employed to offer power to the distributors of 4Life with the exclusivity on the market. The patents of 4Life provide theirs safety to our distributors in many future decades.
4Life it is provided with offices in five continents to give service to a world network of independent distributors across the science, the success and the service.
For more information:
Calvin Jolley
Vice-president of Communications
4Life Research USA, LLC
CalvinJolley@4life.com/801-562-3618
Published in Factors of Transference |
Tags: 4life, exclusive interview, it formulates, global, new, patents, patent, tf cardio, transfer cardio factor, US, uspto |
The comments are closed.
4life, exclusiva, formula, global, nueva, patenta, patente, tf cardio, transfer factor cardio, US, uspto |
Los comentarios están cerrados.